An Emergency Service Example During the Pandemic: Bandırma
DOI:
https://doi.org/10.5281/zenodo.17593448Keywords:
COVID-19, Emergency Medicine, OutcomeAbstract
Background: The ongoing global pandemic has underscored the pressing need to comprehend the long-term ramifications of the condition on those who have survived, with a particular emphasis on respiratory health. The present study investigates the association between a history of infection with the SARS-CoV-2 virus and the outcome of a subsequent acute respiratory disease in hospitalized patients, with the objective of elucidating the long-term respiratory implications of the disease.
Methods: The present retrospective study analyzed data from 394 patients admitted to the emergency department with acute respiratory conditions and hospitalized between November 2022 and March 2023. The data set included demographics, comorbidities, and history of SARS-CoV-2 infection, as well as the primary outcome data (death or intensive care unit admission).
Results: Among 394 patients, a history of infection with the novel coronavirus was associated with a significant increase in adverse outcomes, including death or admission to the intensive care unit. The risk exhibited variation according to the severity of the preceding infection; patients receiving ICU treatment exhibited a higher risk, while those treated in wards exhibited a lower risk. Multivariate analysis identified diabetes, Alzheimer's disease and dementia, and ICU treatment for previous severe acute respiratory syndrome as significant predictors of adverse outcomes, while benign prostatic hyperplasia (BPH) and ward treatment emerged as protective factors.
Conclusions: The findings emphasize the significance of customized post-discharge care and underscore the necessity for ongoing research to elucidate the long-term ramifications of the novel coronavirus, thereby facilitating more effective clinical management and enhancing patient outcomes.
References
1. Dixit NM, Churchill A, Nsair A, Hsu JJ. Post-Acute COVID-19 Syndrome and the cardiovascular system: What is known? Am Heart J Plus 2021;5:100025.
2. Niebauer JH, Binder-Rodriguez C, Iscel A, et al. Cardiopulmonary long-term sequelae in patients after severe COVID-19 disease. J Clin Med 2023;12:1-14.
3. Huang L, Yao Q, Gu X, et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet 2021;398:747-58.
4. Kersten J, Wolf A, Hoyo L, et al. Symptom burden correlates to impairment of diffusion capacity and exercise intolerance in long COVID patients. Sci Rep 2022;12:8801.
5. Maiese A, Frati P, Del Duca F, et al. Myocardial pathology in COVID-19-associated cardiac injury: a systematic review. Diagnostics (Basel) 2021;11:1-14.
6. Raman B, Bluemke DA, Luscher TF, Neubauer S. Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur Heart J 2022;43:1157-72.
7. Ehrenfeld M, Tincani A, Andreoli L, et al. Covid-19 and autoimmunity. Autoimmun Rev 2020;19:102597.
8. Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med 2021;27:601-15.
9. Halawa S, Pullamsetti SS, Bangham CRM, et al. Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: a global perspective. Nat Rev Cardiol 2022;19:314-31.
10. Blanco JR, Cobos-Ceballos MJ, Navarro F, et al. Pulmonary long-term consequences of COVID-19 infections after hospital discharge. Clin Microbiol Infect 2021;27:892-96.
11. Vargas Centanaro G, Calle Rubio M, Alvarez-Sala Walther JL, et al. Long-term outcomes and recovery of patients who survived COVID-19: lung injury COVID-19 study. Open Forum Infect Dis 2022;9:ofac098.
12. O'Reilly S. Pulmonary fibrosis in COVID-19: mechanisms, consequences and targets. QJM 2023;116:750-54.
13. Tuncer G, Geyiktepe-Guclu C, Surme S, et al. Long-term effects of COVID-19 on lungs and the clinical relevance: a 6-month prospective cohort study. Future Microbiol 2023;18:185-98.
14. Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 2021;397:220-32.
15. Zeng N, Zhao YM, Yan W, et al. A systematic review and meta-analysis of long term physical and mental sequelae of COVID-19 pandemic: call for research priority and action. Mol Psychiatry 2023;28:423-33.
16. Ribeiro Carvalho CR, Lamas CA, Chate RC, et al. Long-term respiratory follow-up of ICU hospitalized COVID-19 patients: Prospective cohort study. PLoS One 2023;18:e0280567.
17. Sirayder U, Inal-Ince D, Kepenek-Varol B, Acik C. Long-term characteristics of severe COVID-19: respiratory function, functional capacity, and quality of life. Int J Environ Res Public Health 2022;19:6304.
18. Calcaianu G, Degoul S, Michau B, et al. Mid-term pulmonary sequelae after hospitalisation for COVID-19: The French SISCOVID cohort. Respir Med Res 2022;82:100933.
19. Wang F, Kream RM, Stefano GB. Long-term respiratory and neurological sequelae of COVID-19. Med Sci Monit 2020;26:e928996.
20. Shah W, Hillman T, Playford ED, Hishmeh L. Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ 2021;372:n136.
21. Adeloye D, Elneima O, Daines L, et al. The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease. Lancet Respir Med 2021;9:1467-78.
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Ülkü Açıksöz, Duygu Durmaz
This work is licensed under a Creative Commons Attribution 4.0 International License.
